Large-Scale, Automated Production of Adipose-Derived Stem Cell Spheroids for 3D Bioprinting
March 31st, 2022
Here, we describe the large-scale production of adipose-derived stromal/stem cell (ASC) spheroids using an automated pipetting system to seed the cell suspension, thus ensuring homogeneity of spheroid size and shape. These ASC spheroids can be used as building blocks for 3D bioprinting approaches.
Overview
This article describes a protocol for the large-scale production of adipose-derived stromal/stem cell (ASC) spheroids using an automated pipetting system. This method enhances the homogeneity of spheroid size and shape, making them suitable for 3D bioprinting applications.
Key Study Components
Area of Science
- Cell culture
- 3D bioprinting
- Stem cell research
Background
- Traditional methods of 3D cell culture can be prone to human error.
- Microbiological contamination is a significant concern in cell culture.
- Automated systems can optimize the production process.
- Quality of spheroids is influenced by software parameters.
Purpose of Study
- To reduce human errors in spheroid production.
- To minimize contamination risks.
- To produce thousands of spheroids efficiently for research and applications.
Methods Used
- Automated pipetting system for cell suspension seeding.
- Use of serological pipettes for harvesting stem cell suspension.
- Transfer of cell suspension to centrifuge tubes for processing.
- Testing with cell culture media to optimize conditions.
Main Results
- Successful production of uniform ASC spheroids.
- Reduction in labor hours required for spheroid generation.
- Improved quality control through automation.
- Demonstration of the method's effectiveness in a visual format.
Conclusions
- The automated method enhances the reliability of spheroid production.
- It provides a scalable solution for 3D bioprinting applications.
- Future studies can build on this protocol for various applications.
Frequently Asked Questions
Executive Industry Relevance
Large-scale, automated production of adipose-derived stem cell (ASC) spheroids addresses a critical bottleneck in 3D bioprinting workflows by enabling reproducible, contamination-minimized generation of uniform building blocks. This capability enhances predictive confidence in tissue engineering and supports scalable, high-throughput biofabrication pipelines. Reliable spheroid production directly impacts the translational potential of engineered tissues for preclinical and discovery-stage applications.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables robust hypothesis testing of cell-cell and cell-matrix interactions in 3D microenvironments.
- Supports biological de-risking by providing physiologically relevant tissue models.
- Facilitates functional target validation through standardized, reproducible spheroid systems.
Screening & Assay Development
- Prepares validated, homogeneous spheroids for downstream compound screening and assay development.
- Improves assay reproducibility and quantitative output consistency by minimizing human error and contamination.
- Enables scalable production of assay-ready 3D microtissues for high-throughput workflows.
Translational & Preclinical Research
- Provides disease-relevant 3D tissue constructs for translational modeling and biomarker studies.
- Ensures continuity from discovery through preclinical validation by standardizing spheroid quality and size.
- Reduces risk in advancing tissue constructs toward in vivo and translational studies.
Pipeline & Workflow Integration
This automated spheroid production method fits at the interface of early discovery, assay development, and preclinical model generation, supporting the transition from hypothesis-driven research to scalable tissue engineering.
- Discovery Biology: Supports mechanistic studies by enabling controlled 3D culture environments for hypothesis testing.
- Screening: Delivers reproducible, quantitative spheroid outputs for compound evaluation and assay standardization.
- Analytics: Provides measurable, homogeneous spheroid populations for comparative analysis across conditions.
- Translational Research: Aligns with biomarker and disease modeling needs by producing physiologically relevant 3D constructs.
- Enterprise Reuse: Establishes a scalable, automated capability for repeated use across multiple R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in 3D tissue modeling.
- Operational Value: Standardizes production, reduces labor hours, and minimizes contamination risk.
- Strategic Value: Enables better go/no-go decisions and capital efficiency by supporting high-throughput, reproducible workflows.
- Portfolio Impact: Facilitates risk-adjusted prioritization and advancement of tissue engineering projects.
Implementation Considerations
- Requires expertise in stem cell culture and 3D bioprinting workflows.
- Needs access to automated pipetting systems and micromolded hydrogel infrastructure.
- Demands cross-team standardization of software parameters and quality control protocols.
- Adaptation may be needed for different cell types or hydrogel formats.
- Homogeneity and viability must be routinely validated to ensure downstream reliability.
Biopharma FAQs
Chapters in this video
0:05
Introduction
0:55
Trypsinization of ASC Monolayer at Passage Three
1:45
Micro Molded Non-Adherent Agarose Hydrogel Fabrication
2:31
Bio-Fabrication of ASC Spheroids Using the Automated Pipetting System
5:48
Results: Automated Pipette System for Large-Scale Generation of ASC Spheroids
7:17
Conclusion
